| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.1 | 0.6 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.1 | 0.6 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.1 | 0.6 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.025 | 0.6 |